Scemblix 20 mg (Asciminib (Asciminib Hydrochloride) TABLET) 20 MG

SCEMBLIX 20 MG tablets contain asciminib hydrochloride, a targeted therapy for specific medical conditions. This medication is designed to help manage certain health issues by interfering with abnormal cell growth.

Strength

20 MG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SCEMBLIX 20 MG tablets are primarily used in the treatment of chronic myeloid leukemia (CML). This medication works by targeting specific proteins involved in the growth of cancer cells, helping to slow or stop their proliferation. Patients often wonder, 'What is SCEMBLIX used for?' It is typically prescribed for adults with CML who have developed resistance or intolerance to other treatments.

Side Effects

Common effects of SCEMBLIX 20 MG tablets may include fatigue, nausea, and muscle pain. Some individuals might experience changes in blood cell counts, which can lead to increased susceptibility to infections or bleeding. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

SCEMBLIX 20 MG tablets should be handled with care. Patients should avoid crushing or breaking the tablets. It's crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular blood tests may be necessary to monitor the medication's effects on the body.

Avoid Interactions

SCEMBLIX 20 MG tablets may interact with certain medications, including those that affect liver enzymes. It's important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Avoiding alcohol and certain foods that may interfere with the medication's effectiveness is also advisable.

Frequently Asked Questions

SCEMBLIX 20 MG tablets are used to treat chronic myeloid leukemia (CML) in adults who have developed resistance or intolerance to other treatments.

SCEMBLIX 20 MG tablets are taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, muscle pain, and changes in blood cell counts.

SCEMBLIX may interact with certain medications. Always inform your healthcare provider about all medications you are taking.

The safety of SCEMBLIX during pregnancy has not been established. Consult your healthcare provider for personalized advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.